Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Asset Utilization Ratio: 2016-2025

Historic Asset Utilization Ratio for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to 0.05.

  • AC Immune's Asset Utilization Ratio fell 55.69% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year decrease of 55.69%. This contributed to the annual value of 0.12 for FY2025, which is N/A change from last year.
  • AC Immune's Asset Utilization Ratio amounted to 0.05 in Q3 2025, which was down 83.12% from 0.28 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Asset Utilization Ratio registered a high of 0.28 during Q2 2025, and its lowest value of -0.01 during Q2 2022.
  • For the 3-year period, AC Immune's Asset Utilization Ratio averaged around 0.09, with its median value being 0.03 (2023).
  • Within the past 5 years, the most significant YoY rise in AC Immune's Asset Utilization Ratio was 440,039.77% (2022), while the steepest drop was 274,276.13% (2022).
  • Over the past 5 years, AC Immune's Asset Utilization Ratio (Quarterly) stood at -0.00 in 2021, then spiked by 89,162.30% to 0.01 in 2022, then plummeted by 34.93% to 0.01 in 2023, then soared by 2,770.33% to 0.22 in 2024, then crashed by 55.69% to 0.05 in 2025.
  • Its last three reported values are 0.05 in Q3 2025, 0.28 for Q2 2025, and 0.27 during Q1 2025.